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Edited by David LambethAbstract Oxidative stress is known to produce tissue injury and
to activate various signaling pathways. To investigate the molec-
ular events linked to acute oxidative stress in mouse liver, we in-
jected a toxic dose of paraquat. Liver necrosis was ﬁrst observed,
followed by histological marks of cell proliferation. Concomi-
tantly, activation of the MAP kinase pathway and increased lev-
els of the anti-apoptotic protein Bcl-XL were observed. Gene
expression proﬁles revealed that the diﬀerentially expressed
genes were potentially involved in cell proliferation. These data
suggest that paraquat-induced acute oxidative stress triggers
the activation of regeneration-related events in the liver.
 2006 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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kinases1. Introduction
Reactive oxygen species (ROS) are generated in aerobic
organisms during biochemical processes as well as in response
to various endogenous or exogenous stimuli. Cells contain two
antioxidant defense systems: one is enzymatic and directly de-
stroys ROS; the other is non-enzymatic and scavenges the pre-
formed free radicals to minimize ﬂuctuations in ROS. When
ROS production is increased, the antioxidant capacity of the
cell is overwhelmed, resulting in oxidative stress which is in-
volved in several pathological systems such as inﬂammation,
atherosclerosis and carcinogenesis [1–3]. One potential mecha-
nism of oxidative stress consists in direct damage to macromol-Abbreviations: BrdU, 5-bromo-20-deoxyuridine; ERKs, extracellular
signal-related kinases; Ga, guanine nucleotide binding protein alpha
sub-unit; MAPK, mitogen-activated protein kinase; PI 2, serine prot-
ease inhibitor; ROS, reactive oxygen species; TBS, Tris buﬀered saline;
Wt1, Wilm’s tumor homolog
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doi:10.1016/j.febslet.2006.06.006ecules [4]. However, the toxic eﬀects of oxidative stress on cells
depend upon the intensity of the stress and/or the cell type. In
hepatoma cells, low ROS concentrations have been shown to
increase the antioxidant enzyme activity and to promote cell
proliferation. Conversely, high concentrations of ROS induced
apoptosis or necrosis [5,6]. Recent studies suggest that ROS
possibly act as second messengers for transcription activation,
apoptosis, cell growth and chemotaxis [7]. Mechanisms by
which ROS alter signal transduction and gene expression have
been described for cell proliferation and apoptosis induced by
mild oxidative stress. On the other hand, the necrosis induced
by severe oxidative stress is poorly understood at the molecu-
lar level while more is known about the role of antioxidants
[8,9].
1,1-Dimethyl-4,4-bipyrimidyl chloride (paraquat), is a herbi-
cide previously used to induce hepatocyte toxicity in vitro via
oxidative stress [10]. Paraquat has also been shown to be
highly toxic for mammals including humans and to cause se-
vere injuries to many organs such as lungs, liver and kidney
[11].
To identify the molecular events involved in acute oxidative
stress in liver, we treated mice with a high dose of paraquat.
We studied some signaling pathways activated by oxidative
stress in control and paraquat-treated mice, according to the
morphological and biochemical modiﬁcations induced by
paraquat in the liver. Concurrently, the transcriptomes of con-
trol and treated mice were assessed by using large-scale cDNA
microarrays and Northern blot analysis.2. Materials and methods
2.1. Animals
Eighty eight weeks C57BL6J male mice, weighing 24–26 g each, were
purchased from Jackson Laboratories (Bar Harbor, USA). They were
kept under standard conditions in our university’s animal facility with
a daily light/darkness cycle 14–10 h, with free access to food and water.
Experiments were performed according to the prescription for the care
and use of laboratory animals (approval 04476 of the Ministry of Agri-
culture, section on Health and Animal Protection). They were given a
standard sterilized commercial diet ‘‘UAR 113’’ purchased from UAR
Laboratories (Bordeaux, France). The animals were then divided in
two equal groups. The experimental group received an intra-peritoneal
injection of paraquat chloride hydrate (Sigma Chemical Co., St. Louis,
MO) at a toxic dose of 50 mg/kg of body weight, dissolved in saline
solution (NaCl 0.09 g/L). The control group received an intra-
peritoneal injection of vehicle. At the same time, both groups receivedblished by Elsevier B.V. All rights reserved.
3846 N. Dragin et al. / FEBS Letters 580 (2006) 3845–3852a single injection of 5-bromo-20-deoxyuridine (BrdU, 120 mg/kg)
(Sigma), a marker of cell proliferation. Mice were killed at the follow-
ing times: 2, 4, 8 and 12 h after the paraquat or vehicle injections to
examine the paraquat-induced biochemical and morphological
changes in the livers. After killing, livers were promptly collected,
rinsed in ice-cold saline solution, and aliquoted for preparation of total
RNA, protein extraction and histological examination. Liver samples
were frozen in liquid nitrogen and stored at 80 C before use.
Simultaneously, blood was collected in heparinized tubes and treated
immediately for biochemical analysis.
2.2. Histological and immunohistochemical analyses
Liver samples were collected 2, 4, 8 and 12 h after paraquat injec-
tion, and 2–3 mm thick pieces of each liver were ﬁxed in 4% formalde-
hyde and paraﬃn-embedded. Sections were processed for hematoxylin
and eosin staining and for immunohistochemistry. The slides were ana-
lyzed on a Zeiss Axioplot 2 microscope and photographed using a
CoolSNAP digital camera (Roper Scientiﬁc, Tucson, AZ).
For assessment of BrdU labeling index (BrdU L.I.), the sections
were treated with anti-mouse BrdU antibody (BD Biosciences Clon-
tech), at a dilution of 1:500. Sections were then counterstained with
hematoxylin for microscopic examination. The sites of peroxidase
bindings were demonstrated by using the EnVision + System kit
(Dako, CA, USA). Sections were counterstained with hematoxylin
for microscopic examination. BrdU labeling indexes correspond to
the percentage of BrdU-positive cells per 2000 hepatocytes.
2.3. Western-blot analysis
Liver aliquots were homogenized on ice in freshly prepared buﬀer
containing 20 mM Tris–HCl, pH 7.5, NaCl 140 mM, 1 mM EDTA,
50 mMNaF, NP40 1% and a mixture of protease inhibitors containing
50 U/ml aprotinin (Sigma), 200 mM sodium orthovanadate (Calbio-
chem, San Diego, CA) and 100 mM PMSF (Boerhinger Mannheim
corporation, Indianapolis, USA). The lysates were cleared by centrifu-
gation at 14000 · g for 20 min at 4 C. The protein content of the
supernatant was measured with Bradford reagent [12]. Proteins were
resolved on 12% SDS–PAGE and transferred onto polyvinylidene
diﬂuoride membranes (PVDF, Sigma). Non-speciﬁc binding sites were
blocked with Tris buﬀered saline (TBS) containing 5% fat powdered
milk. Membranes were then incubated overnight at 4 C with primary
antibody in TBS containing 5% bovine serum albumin. Rabbit anti-
p42/44 ERK and anti-phospho p42/44 ERK (Cell Signaling Technology
Inc., Beverly, MA, USA), mouse anti-BCL-XL (Santa Cruz Biotech-
nology, Santa Cruz, CA, USA), rabbit anti-CREB and anti-phospho
CREB (Santa Cruz), rabbit anti-p38 and anti-phospho-p38 (Cell Sig-
naling), and mouse anti-b actin (Sigma) were used as primary antibod-
ies. After washing three times in TBS, membranes were incubated with
appropriate secondary antibodies conjugated to horseradish peroxi-
dase. Then, the membranes were washed three times with TBS, and
the proteins of interest were visualized with the Covalight Detection
System (CovalAb, Oullins, France).
2.4. RNA isolation
Liver samples were immediately transferred to a Trizol solution
(Gibco-BRL, Eggenstein, Germany) and stored at 80 C before
RNA isolation. Total RNA was isolated from each individual liver
according to the manufacturer’s protocol. The amount of RNA was
determined by measuring absorption at 260 nm. Quality of the isolated
RNA was controlled by the 260/280 nm ratio and by electrophoresis in
denaturant agarose gel.
2.5. cDNA array analyses
Total RNA (5 lg) from six diﬀerent livers of each group (control
and 12 h paraquat-treated) were pooled to prepare cDNA probes by
simultaneous reverse transcription and labeling with 32P according
to the Clontech (Palo Alto, CA, USA) procedure. The 32P labeled
cDNA probes were further puriﬁed by column chromatography
(Nuc TrapR Probe puriﬁcation column, Stratagene, La Jolla, CA,U-
SA). The Atlas Mouse 1.2 Array containing 1176 mouse cDNAs
was purchased from Clontech. The diﬀerent probes (3 · 106 cpm/ml)
were hybridized for 48 h at 68 C on separate ﬁlter arrays, and the ﬁl-
ters were washed according to the manufacturer’s instructions. After
exposure to a PhosphorImager (Typhoon, Amersham Pharmacia Bio-tech, Orsay, France), the images were analyzed using the AtlasImage
TM software (Clontech, UK). Results were evaluated by using the
ImageQuant software (Amersham Pharmacia Biotech). Two diﬀerent
hybridizations were performed with the control pool probes and with
the treated pool probes [13]. After subtraction of the background, sig-
nal values were normalized by dividing by the mean ﬁlter hybridiza-
tion signal. No signals were detected in the spots of plasmid or
bacteriophage DNA, conﬁrming the speciﬁcity of the hybridization.
For each gene, the treated/control ratio was calculated by dividing
the average value obtained for the two independent hybridizations
performed with the treated pooled samples by the average value of
the two independent hybridizations performed with the control pooled
samples. Only signal ratios higher than two were considered as ex-
pressed diﬀerentially.
2.6. Northern blot analysis
The RNA samples were loaded in a 1.5% denaturant agarose gel,
transferred to Hybond-N+ nylon membranes (Amersham Biosciences,
Orsay, France) and cross-linked to the membranes by UV irradiation
(UV Stratalinker 1800, Stratagene). Four probes were prepared from li-
ver cDNAs obtained with the Advantage Kit for RT-PCR (Clontech).
Theywere chosen according to their diﬀerential expression assessedwith
DNA arrays and ampliﬁed with the following primers: Glutathione
reductase (Genbank Accession No. X76341) 5 0AGTTCCTCACGA-
GAG, 3 0CCAGGCCTGATGATGTCTTT; Cathepsin C (Genbank
Accession No. U89269), 5 0CTTGGGACTGGAGAAACGTC, 3 0
CCTTGGTTTGCATGCAGAAT; Ga (Genbank Accession No.
Y00703), 5 0AGTTCGCTCGCTACACCACT, 3 0TGAAGGGAAGA-
GGGGTTTTT. The probe sequences were veriﬁed on a CEQ 2000
DNA analysis system (Beckman-Coulter, France). Pre-hybridizations
and hybridizations were performed using ULTRAhyb solution (Am-
bion Clinisciences, Montrouge, France). Labeling of cDNA probes to
a speciﬁc activity of 5 · 108–2 · 109 cpm/lg was obtained using a
Prime-it II random primer labeling kit (Stratagene). The membranes
were washed and exposed in a PhosphorImager cassette and signals were
quantiﬁed using the ImageQuant software (Amersham Pharmacia).
Experiments were performed on the RNA liver samples of four treated
and four untreated mice. Moreover, each experiment was performed in
duplicate and the duplicate datamatched closely. Themean of the dupli-
cates was used for subsequent calculations.
2.7. Statistical analysis
Statistical analysis was performed using one-way ANOVA analysis
or the two-tailed unpaired Student’s t test with Sigmastat for Windows
(SPSSInc, Chicago, USA). P values less than 0.05 were considered
signiﬁcant.3. Results and discussion
3.1. Paraquat induces early necrosis and stimulates subsequent
liver regeneration
To assess the morphological impact of the paraquat treat-
ment, livers of treated and control mice were sectioned and
examined using histological techniques. Liver sections from
paraquat-treated mice showed focal and degenerative changes
compared to controls. Two hours after paraquat injection,
hepatocytes exhibited typical features of necrosis with slight
hepatic collapse (Fig. 1B) followed by pericentrilobular coagu-
lation at 4 h (Fig. 1C). After 12 h, the hallmark of necrosis was
still present in association with inﬂammation signs character-
ized by accumulation of leukocytes (Fig. 1D).
The hepatic insult was conﬁrmed at the biochemical level
since a signiﬁcant increase in alanine aminotransferase
(ALT) activity, a commonly used marker of liver cytolysis
[14], was demonstrated. As shown in Fig. 1E, ALT activity
in plasma samples peaked at 4 h (25·, P < 0.001), then
dropped to threefold the normal value at 12 h, suggesting a
decrease in hepatocyte cytolysis.
Fig. 1. Eﬀect of paraquat treatment on mouse liver histology and plasma ALT activity. For histological analysis, livers were ﬁxed and sectioned after
paraﬃn-embedding, and sections were stained with hematoxylin and eosin. (A) Mouse control liver. (B)–(D) Mouse livers treated by paraquat at 2 h,
4 h and 12 h, respectively. Double arrows point to hepatocyte architecture disruption, arrow head shows pericentrilobular coagulation and arrow
indicates leukocyte accumulation. Magniﬁcation 200·. (E) Plasma ALT activity determined at each time point in paraquat-treated mice (n = 4 for
each time point) and in controls (n = 4). Data are means ± S.E.M. *P < 0.05, **P < 0.001.
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were observed on the slides, a ﬁnding conﬁrmed by the absence
of TUNEL-positive cells (data not shown). Although previous
in vivo studies have shown that a moderate dose of paraquat
may elicit liver aponecrosis in mice, a process of cell death
sharing characteristics of both apoptosis and necrosis [15],
other data obtained in vitro demonstrated that an acute oxida-
tive stress can result in necrosis of hepatocytes instead of apop-
tosis [16]. The dose used in vivo in the present study
corresponds to almost four times the dose administered in mice
by Cheng’s group [15]. Therefore, our results show that a toxic
dose of paraquat induces liver necrosis without apoptosis.
It is well known that liver is very reactive to surgical, micro-
biological or chemical trauma and reacts by an immediate
adaptive regeneration response [17]. BrdU is a thymidine ana-log that is incorporated into DNA during DNA synthesis and
which is used to mark proliferating cells [18]. Interestingly, as
shown in Fig. 2C, BrdU incorporation signiﬁcantly increased
by threefold 12 h after paraquat administration, suggesting a
secondary proliferative process occurring immediately after
the primary necrosis of the hepatocytes. This eﬀect is not sur-
prising since in the lungs, the main target for paraquat poison-
ing, an early destructive episode was reported to be rapidly
followed by a proliferative reaction [19]. Similarly, and
although the kinetics is diﬀerent probably because of the
occurrence of diﬀerent side eﬀects, Taniguchi et al. [14] showed
that carbon tetrachloride CCl4, a widely used ROS generating
agent, induces necrosis at an early stage, followed by hepato-
cyte regeneration in the late stage of the injury. Consistently,
our histological and biochemical results suggest that treatment
Fig. 2. Eﬀect of paraquat treatment on mouse liver BrdU incorporation. Histological BrdU labeling in controls (A) and in 12 h paraquat-treated
mice (B). Arrow heads show positive BrdU labelling nuclei. Bars: 50 lm. (C) Time course of quantitative BrdU labeling in controls and in paraquat-
treated mice (n = 4 for each time-point). Data are means ± S.E.M. *P < 0.05.
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sis (4 h) followed by cell regeneration (8–12 h).
3.2. Oxidative stress activates proteins involved in proliferation
control
To examine the signaling pathways involved in the observed
proliferation reaction, we evaluated the stimulation of intracel-
lular signaling molecules involved in the activation of the cell
cycle.
The mitogen-activated protein kinase (MAPK) pathway is
one of the most important pathways known to be associated
with cell proliferation. It consists in the sequential activation
of a series of protein kinases on serine/and or threonine resi-
dues and it relays the signals of diﬀerent types of membrane
receptors to the nucleus after stress or mitogenic stimulation
[20]. We focused on the ERK1 (p-44 MAPK), ERK2 (p-42
MAPK) and p-38MAPK which are key enzymes of the MAPK
cascade. Adult hepatocytes are quiescent cells which remain in
the G0 phase of the cell cycle but are able to re-enter the cell
cycle in response to injury [21]. Acute activation of the MAPK
cascade has been demonstrated in vitro to promote G1 pro-
gression and S phase entry while chronic activation of MAPK
cascade inhibits this process [22]. Whereas extracellular signal-
related kinases (ERKs) 1/2 is considered as the archetypical
pro-proliferative MAPKs in cells demonstrating a rapid turn-
over [23], p38 MAPK is also thought to play a role in hepato-
cyte proliferation and several studies have demonstrated that
activation of p38 MAPK correlates with cell cycle entry
[24,25]. Total ERK 1/2 and p38 MAP kinase cell concentra-
tions were found constant by western blotting throughout
the experiment (Fig. 3A). However, the corresponding phos-
phorylated activated forms progressively increased andreached a maximum level at 12 h for phospho-ERK1/2
(P < 0.025 and P < 0.005, respectively) and at 8 h for phos-
pho-p38 MAP kinase (P < 0.01) (Fig. 3B). These data suggest
a possible link between the activation of ERK1/2 and p38
and the proliferation of the hepatocytes following paraquat
injection.
Another prominent molecule associated with cell prolifera-
tion is the transcription factor CREB. CREB has been found
to be activated after hepatectomy [26] and its phosphorylation
constitutes an early step to trigger hepatocyte proliferation
[27]. Interestingly, an increase in CREB activation was also ob-
served after paraquat treatment, as evaluated by CREB phos-
phorylation. This CREB activation pattern is qualitatively and
quantitatively very similar to that of p38 since it peaks at 8 h
(P < 0.01). Thus, three proteins known to be associated with
hepatocyte proliferation were found to be signiﬁcantly acti-
vated as soon as 8 h after paraquat treatment.
We found no morphological signs of apoptosis. Among
the anti-apoptotic proteins of the Bcl-2 family present in li-
ver [28], we found that the level of Bcl-XL was signiﬁcantly
increased in treated hepatocytes in a time-dependent manner
(Fig. 3B). This corroborates our histological analysis and
suggests that the hepatocytes of paraquat-treated mice rap-
idly increased their anti-apoptotic defenses to promote cell
survival.
3.3. Few genes are upregulated at the later stage of injury
The ﬁnal outcome of the activation of the pathways studied
here is the modulation of gene transcription. Therefore, a dif-
ferential survey of the transcriptome from controls and treated
mice was performed 12 h after paraquat administration, when
the activation of the MAP kinase pathway is maximal.
Fig. 3. Time course eﬀect of paraquat treatment on phosphorylation of ERK 1/2, p38, CREB and on Bcl-XL expression. (A) Western blots were
performed on total protein extracts from paraquat-untreated (n = 4 for each time-point) and treated mice (n = 4) using speciﬁc antibodies to ERK1/2,
p-38, CREB, Bcl-XL and phospho-antibodies to ERK 1/2, p 38 and CREB. Time zero refers to controls. (B) The bands were quantiﬁed by
densitometry and the relative intensity of each band to b-actin control was determined. Data are means ± S.E.M. of immunoblot band densities of
four independent experiments. *P < 0.05, **P < 0.025, ***P < 0.01, ****P < 0.005.
N. Dragin et al. / FEBS Letters 580 (2006) 3845–3852 3849In two independent cDNA array experiments, 100% of the
1176 genes displayed a signal above the background value in
both groups (http://cbi.labri.fr/outils/data/dragin/). Only 20
genes were signiﬁcantly expressed diﬀerentially according toTable 1
Genes diﬀerentially expressed in paraquat-treated mouse livers compared to
Gene/protein name (other name)
Cathepsin C
Gap junction membrane channel protein beta 1 (connexin 32)
Myosin light chain, alkali, non-muscle
Fibronectin 1
Soc-2 (suppressor of clear) homolog (C. elegans) (Ras-binding
protein SUR-8)
DnaJ (Hsp 40) homolog, subfamily C, member 3 (p 58)
Cathepsin H
Cathepsin D
Serine protease inhibitor 2 related sequence 1
Tyrosine 3-monooxygenase/tryptophan 5-monooxygenase (14-3-3 eta)
Thymoma viral proto-oncogene 1 (AKT1)
Amino-terminal enhancer of split (related to Drosophila groucho gene)
Cathepsin B
Sema domain, immunoglobulin domain (Ig), transmembrane domain
(TM) and short cytoplasmic domain, (semaphorin 4A )
V-erb-b2 erythroblmastic leukemia viral oncogene homolog 3 (avian) (Erbb
Hepsin
Retinoid X receptor alpha
Wilm’s tumor homolog
Serine protease inhibitor 1–2
GNAS (guanine nucleotide binding protein alpha stimulating) complex locu
aRatios were calculated by dividing the average value from two independent e
value of the control sample pool (n = 6).the selected criteria (signal ratios higher than 2) in liver sam-
ples from treated mice as compared to controls. Three genes
displayed a positive ratio (twofold increase), and 17 had a
negative ratio (twofold decrease, Table 1). The diﬀerentiallycontrol mouse livers
GenBank Accession no. Paraquat/control ratioa
U89269 5.9
M63802 5.3
U04443 5.2
X82402 5.0
AF068921 3.7
U28423 3.3
U06119 2.9
X53337 2.7
X69832 2.4
U57311 2.4
M94335 2.4
L12140 2.2
M14222 2.2
X85991 2.2
3) L47240 2.0
AF030065 2.0
M84817 2.0
M55512 2.3
M75716 3.2
s Y00703 3.5
xperiments obtained for the treated sample pool (n = 6) by the average
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tein turn-over, signal transduction, cell receptors, membrane
channel transporters, cytoskeleton scaﬀolding, apoptosis,
oncogenes and tumor suppressors.
To validate the results of the cDNA arrays, Northern blot
analyses were performed on three genes selected according to
the ratios obtained by the array method: Cathepsin C which
was signiﬁcantly repressed, the guanine nucleotide binding
protein alpha sub-unit (Ga) which was overexpressed and glu-
tathione reductase which was at the limit of diﬀerential expres-
sion (1.8 ratio) according to the criteria chosen. Calculated
treated/untreated ratios (Fig. 4) were comparable to those ob-
tained by the cDNA array approach, conﬁrming the reliability
of the method used.
Interestingly, the three upregulated genes, namely Ga,
Wilm’s tumor homolog (Wt1) and the serine protease inhib-
itor 1–2 (PI 2), encode proteins known to be associated with
the control of cell proliferation. Recent studies suggest that
a, b, c subunits may form preferred G protein trimers and
that functional variety may result from distinct abc subunit
combinations [29]. In addition, each G protein subtype
shows cell-speciﬁc or temporal patterns of expression [30]
raising the possibility that each cell contains only a subset
of all possible G protein abc combinations, which therefore
act downstream of receptors in a speciﬁc manner. Therefore,
the rise in G-alpha subtype gene expression could be an
adaptive modiﬁcation of the subunit repertoire of G protein
trimers in response to paraquat injury. In fact, it was re-
cently shown that the Ga subunit may interfere with various
signaling pathways, such as phospholipase Cc (PCL-c) acti-
vation by epidermal growth factor (EGFR), to control liver
regeneration in the event of chronic alcohol consumption
[31]. However, whether paraquat-induced G-alpha gene
expression is related to hepatocyte proliferation remains to
be established. The Wt1 gene encodes a transcription factor
with zinc ﬁnger motifs and regulates the expression of many
genes associated with growth, diﬀerentiation and apoptosis
[32]. Recent reports using a model of liver regeneration from
undiﬀerentiated progenitor cells suggest an important role
for Wt1 in hepatocyte proliferation and diﬀerentiation
[33,34]. Accordingly, the observed increase in Wt1 gene
expression is in agreement with the regeneration process ob-
served in the livers of paraquat-treated animals. PI 2 is aFig. 4. Representative Northern blot analysis of genes either found
overexpressed or repressed in cDNA array experiments. (A) Total
RNAs were extracted and 30 lg were resolved on a denaturing 1.2%
agarose gel. RNAs were transferred onto a nylon membrane and
hybridized with the speciﬁc probes indicated on the right. (B) Signals
were quantiﬁed on a phosphorimager with ImageQuant (Molecular
Dynamics). Data are expressed as the means ± S.E.M. of treated/
untreated ratios of gene expression calculated with RNA samples of
four individual treated and four untreated mice. Each experiment was
performed in duplicate.hepatocyte acute-phase reactant [35] whose levels rise sharply
following tissue injury or inﬂammation. In addition to its
protease inhibitory function, PI 2 has been shown to be a
potent promoter of ﬁbroblast proliferation, possibly through
the activation of the MAPK signaling pathway [36]. The in-
crease in PI 2 RNA level could also be a response to MAP
kinase phosphorylation, both events occurring concomitantly
to trigger cell proliferation.
It has already been pointed out that absence of apoptosis
was positively correlated with an increase in the active form
of the pro-survival protein Bcl-XL. In vivo, Bcl-XL is inacti-
vated by the association with the pro-apoptotic protein BAD
[37]. Disruption of the Bcl-XL/BAD complex, which results
in the release of the Bcl-XL active form, is achieved after
BAD phosphorylation by AKT and is sustained by sequestra-
tion of the phosphorylated BAD by the 14-3-3 complex [38].
The down-regulation of both the thymoma viral proto-onco-
gene 1 (AKT) and the tyrosine 3-monooxygenase (14-3-3 eta)
genes might be considered incompatible with the increase in
Bcl-XL observed after paraquat treatment. However, other ki-
nases have been described to eﬃciently target BAD [39,40],
therefore preventing its association with Bcl-XL. In addition,
seven individual genes encoding seven diﬀerent 14-3-3 isotypes
have been described. These isotypes contribute to the forma-
tion of 14-3-3 homo- or heterodimers complexes, which are
all able to eﬃciently sequester BAD [39,40]. Consequently,
the downregulation of AKT and 14-3-3 eta genes points to a
paraquat-induced disruption of the Bcl-XL activating process.
Additional experiments involving the study of post-transla-
tional modiﬁcations of proteins involved in this pathway are
clearly needed to further address this issue.
In contrast, it was recently demonstrated that, when released
from the lysosomes into the cytoplasm, cathepsins may trigger
apoptotic cell death via various pathways including the activa-
tion of caspases and the release of pro-apoptotic factors from
the mitochondria [41,42]. The downregulation of cathepsins C,
H, B and D genes evidenced in this study is consistent with this
view.
Among the other genes found to be down-regulated, some
are involved in cell growth, migration and diﬀerentiation.
These eﬀects are possible through interactions with the extra-
cellular matrix such as ﬁbronectin [43], the organization of
the cytoskeletal network involving semaphorin 4A [44], or
the Gap junctional intracellular communication pathway with
the gap junction channel protein [45]. In addition, the observed
downregulation of the RXRa gene could be consistent with
other published observations suggesting that this phenomenon
is a natural response to the increase in intracellular H2O2 in
hepatocytes after oxidative stress injury [46].4. Conclusion
This study is the ﬁrst to demonstrate hepatocyte regenera-
tion in response to paraquat injury in vivo. Morphological
analysis showed the occurrence of a secondary proliferative re-
sponse following early cell necrosis. In addition no sign of
apoptosis could be demonstrated. This proliferation process
was associated with the activation of the MAP kinases (ERKs
1/2 and p38) and the CREB transcription factor concomitantly
with an increase in the protein level of the antiapoptotic
Bcl-XL. In addition, paraquat induced modiﬁcations of the
N. Dragin et al. / FEBS Letters 580 (2006) 3845–3852 3851expression pattern of genes involved in liver regeneration pro-
cess.
In conclusion, the compensatory response of the liver to
paraquat-induced oxidative stress is to maintain its integrity
by triggering regeneration rather than promoting apoptosis.
In addition, this work identiﬁes possible molecular targets use-
ful for the prevention of cellular damage induced by paraquat
toxicity.
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